Sarcopenia and Risk of Pancreatic Fistula after Pancreatic Surgery: A Systematic Review

Postoperative pancreatic fistula (POPF) is one of the most critical complications after pancreatic surgery. The relationship between sarcopenia and outcomes following this type of surgery is debated. The aim of this review was to assess the impact of sarcopenia on the risk of POPF. A literature search was performed using the PubMed database and the reference lists of relevant articles to identify papers about the impact of sarcopenia on POPF in pancreatic surgery. Twenty-one studies published between 2016 and 2021 with a total of 4068 patients were included. Some studies observed a significant difference in the incidence of POPF between the sarcopenic and non-sarcopenic patients undergoing pancreatoduodenectomy. Interestingly, there was a trend of a lower POPF rate in sarcopenic patients than in non-sarcopenic patients. Only one study included patients undergoing distal pancreatectomy specifically. The role of sarcopenia in surgical outcomes is still unclear. A combination of objective CT measurements could be used to predict POPF. It could be assessed by routine preoperative staging CT and could improve preoperative risk stratification in patients undergoing pancreatic surgery.

[1]  A. Porcu,et al.  State of the Art in Pancreatic Surgery: Some Unanswered Questions , 2022, Journal of clinical medicine.

[2]  K. Shirabe,et al.  Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy , 2021, International Journal of Clinical Oncology.

[3]  Mimi Kim,et al.  Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy , 2020, PloS one.

[4]  E. Harrison,et al.  Systematic review and meta‐analysis of factors associated with post‐operative pancreatic fistula following pancreatoduodenectomy , 2020, ANZ journal of surgery.

[5]  M. Heslin,et al.  Preoperative anthropomorphic radiographic measurements can predict postoperative pancreatic fistula formation following pancreatoduodenectomy. , 2020, American journal of surgery.

[6]  B. Song,et al.  Prediction of clinically relevant pancreatic fistula after pancreatic surgery using preoperative CT scan: A systematic review and meta-analysis. , 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[7]  H. Ohdan,et al.  Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy , 2020, BMC Gastroenterology.

[8]  F. Sonohara,et al.  Pancreatic Fat and Body Composition Measurements by Computed Tomography are Associated with Pancreatic Fistula After Pancreatectomy , 2020, Annals of Surgical Oncology.

[9]  D. Choi,et al.  The effects of sarcopenia and sarcopenic obesity after pancreaticoduodenectomy in patients with pancreatic head cancer. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[10]  A. Lauterio,et al.  The Impact of Sarcopenia on Postoperative Course following Pancreatoduodenectomy: Single-Center Experience of 110 Consecutive Cases , 2020, Digestive Surgery.

[11]  Georgi Atanasov,et al.  Power of computed-tomography-defined sarcopenia for prediction of morbidity after pancreaticoduodenectomy , 2019, BMC Medical Imaging.

[12]  J. Windsor,et al.  Impact of preoperative sarcopenia on postoperative outcomes following pancreatic resection: A systematic review and meta-analysis. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[13]  Kyung-Won Kim,et al.  Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI , 2018, European Radiology.

[14]  H. Friess,et al.  Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) , 2018, Surgery.

[15]  Y. Takeda,et al.  Clinical Impact of Preoperative Sarcopenia on the Postoperative Outcomes After Pancreas Transplantation , 2018, World Journal of Surgery.

[16]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[17]  S. Truant,et al.  Impact of sarcopenia on outcomes of patients undergoing pancreatectomy , 2018, Medicine.

[18]  M. Ronot,et al.  Visceral Obesity and Open Passive Drainage Increase the Risk of Pancreatic Fistula Following Distal Pancreatectomy , 2018, Journal of Gastrointestinal Surgery.

[19]  Y. Shimada,et al.  Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy , 2018, Surgery Today.

[20]  H. Ohdan,et al.  Visceral Adipose Tissue and Skeletal Muscle Index Distribution Predicts Severe Pancreatic Fistula Development After Pancreaticoduodenectomy. , 2018, Anticancer research.

[21]  E. Hatano,et al.  Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer , 2017, Annals of Surgical Oncology.

[22]  T. Fujiwara,et al.  Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy , 2017, BMC Surgery.

[23]  D. Gouma,et al.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.

[24]  L. Gianotti,et al.  A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. , 2016, Nutrition.

[25]  M. Coolsen,et al.  Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer , 2016, Journal of cachexia, sarcopenia and muscle.

[26]  M. Besselink,et al.  Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer , 2016, Annals of Surgical Oncology.

[27]  Y. Nishida,et al.  Preoperative Sarcopenia Strongly Influences the Risk of Postoperative Pancreatic Fistula Formation After Pancreaticoduodenectomy , 2016, Journal of Gastrointestinal Surgery.

[28]  M. Braga,et al.  Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery , 2016, The British journal of surgery.

[29]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[30]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[31]  M. Braga,et al.  Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter Study , 2017, Annals of Surgical Oncology.

[32]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[33]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .